Publications

Year of Publicationsort descending Title Faculty Association
2019 Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions. Christopher Cartmell
2019 Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions Christopher Cartmell
2019 Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2019 Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2019 Animal Models for the Study of Bone-Derived Pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2019 A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction. Tally Largent-Milnes, PhD, Kathleen Rodgers, Ph.D., Todd Vanderah, PhD
2020 Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2020 The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression. Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 Lost in the Haze: The Physician's Role in Cannabinoid Prescribing and Advising. Todd Vanderah, PhD
2020 Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS
2020 Development of 3D Printed Drug-Eluting Scaffolds for Preventing Piercing Infection. Christopher Cartmell
2020 Potential therapeutic treatments of cancer-induced bone pain. Todd Vanderah, PhD
2020 Haploinsufficiency of tau decreases survival of the mouse model of Niemann-Pick disease type C1 but does not alter tau phosphorylation. Todd Vanderah, PhD
2020 Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS
2020 Glial neuroimmune signaling in opioid reward. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model. Torsten Falk, Ph.D., Robin Polt, Ph.D., Todd Vanderah, PhD
2020 Heat shock protein 90 inhibitors block the antinociceptive effects of opioids in mouse chemotherapy-induced neuropathy and cancer bone pain models. Tally Largent-Milnes, PhD, John M. Streicher, PhD
2020 Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake. Thomas P Davis, PhD, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2020 DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache. Kelly L Karlage, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2021 An underrepresented majority: A systematic review utilizing allodynic criteria to examine the present scarcity of discrete animal models for episodic migraine. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2021 Sex hormones regulate NHE1 functional expression and brain endothelial proteome to control paracellular integrity of the blood endothelial barrier. Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2021 Development of N,O-Carboxymethyl Chitosan-Starch Biomaterial Inks for 3D Printed Wound Dressing Applications. Christopher Cartmell
2021 The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area. Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD

Pages